Post Categories
Meet QPS at the ATS in Dallas
May 9, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
DDI Studies: The Final Frontier?
May 9, 2019
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
Challenging the Inhaled Allergen Challenge
May 9, 2019
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
QPS will exhibit at the World Vaccine Congress
April 15, 2019
QPS will exhibit at the World Vaccine Congress, April 15-17 in Washington, DC. Please stop by our booth #600 to learn more about QPS’…
BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed…
QPS is exhibiting at the 13th Annual WRIB Meeting
March 27, 2019
QPS is exhibiting at the 13th Annual WRIB Meeting, April 1-4 in New Orleans, LA. If you are attending, please visit us at booth…
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany.
October 4, 2018
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Please stop by our Booth #5 to learn…
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
Translational Medicine Now Bigger and Better at QPS
July 14, 2017
Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult…
Do Obesogens Cause Obesity?
April 12, 2023
For years, obesity and weight gain have been blamed on the “calorie concept”: the idea that obesity is caused by taking in more calories…
Research Reveals How Epidural Electrical Stimulation Helps People Walk Again
April 3, 2023
Building on previous research that showed how epidural electrical stimulation (EES) can help restore walking ability in people with spinal cord injuries, neuroscientists have…
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the…
Can We Reverse Aging by Targeting Old Cells?
March 22, 2023
James Kirkland and Tamara Tchkonia, researchers at the Mayo Clinic, are at the forefront of a movement focused on stopping chronic disease by targeting…
Harnessing the Power of Monoclonal Antibodies in the Fight Against Malaria
March 20, 2023
Monoclonal antibodies have been deployed to treat a variety of diseases, from cancer to COVID-19. Now this treatment approach, which doesn’t depend on the…
First Vaccine for Honeybees Prevents American Foulbrood
March 15, 2023
A healthy honeybee population is a critical component of healthy ecosystems, clean air, and stable soil. Honeybees also play a critical role in food…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…